Codexis strikes technology deal with Merck; Unichem pill mix-up leads to recall;

> Unichem Pharmaceuticals is voluntarily recalling one lot of hydrochlorothiazide blood pressure medication after a clopidogrel blood thinner tablet was found in a bottle. Notice

> Codexis ($CDXS) has licensed its biocatalyst enzyme development technology to Merck ($MRK) in a deal that could earn it up to $18 million. Release

> India's Drug Control Administration (DCA) has served show cause notices on 24 pharmaceutical companies in Hyderabad, two of which had their manufacturing units seized. Story

> Pharma chemical producer Caesar & Loretz (Caelo) is investing more than €10 million ($10.97 million) to modernize and expand its production, warehousing and headquarters in Hilden, Germany. Report

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)